Edaravone
Product Images NDC 39822-4500

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Edaravone (NDC 39822-4500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 mg Carton (30 mg Carton Photo)

Description: A pharmaceutical product with the NDC code 39822-4500-2 is described in the text. It is an Edaravone Injection solution with a concentration of 0.3 mg/mL for intravenous infusion. The package contains two vials, each with a volume of 100mL. The recommended administration involves infusing the contents of each 100mL vial over a 30-minute period.*

FDA Label Image

30 mg Vial (30 mg Vial Photo)

This is a label for Edaravone Injection, containing 30 mg of edaravone along with other inactive ingredients like L-cysteine hydrochloride hydrate. It is intended for intravenous infusion only, with a specific temperature requirement of 25°C (77°F). The text cautions to keep it away from children, not to swallow, and to discard any unused IV solution. The dosage instructions should be checked on the package insert for complete information.*

FDA Label Image

60 mg Carton (60 mg Carton Photo)

The text is a medication label for Edaravone Injection with size specifications of 60 mg/100 ml and a concentration of 0.6 mg/mL for intravenous infusion. The product is identified by the NDC code 39822-4510-1. The text contains information related to dosage administration and storage instructions. The medication is likely used for specific medical purposes requiring exact dosing and administration guidelines.*

FDA Label Image

60 mg Vial (60 mg Vial Photo)

This text provides important information about Edaravone Injection, including the NDC code (39822-4510-1), inactive ingredients, storage instructions, and dosage details. It also includes guidelines to not swallow the injection and to discard any unused IV solution. The text mentions the lot number and expiration date for tracking and verification purposes.*

FDA Label Image

Edrv-structure (Edrv Structure)

FDA Label Image

Figure-1 (Figure 1)

This text provides information about the percentage of patients who experienced changes in their ALSFRS-R score after receiving Edaravone Injection compared to placebo at week 24. The data includes values representing patients who showed improvement or worsening of their condition.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.